Nateraincis A Global Leader In Cell Free Dnacfdnatestingfocusing On Oncologywomenae S Healthand Organ Healthfounded In 2004The Company Operates Clia Certified And Cap Accredited Laboratories In Austintexasand San Carloscalifornianatera Aims To Integrate Personalized Genetic Testing Into Standard Healthcareenabling Early And Targeted Interventions For Better Patient Outcomes The Company Offers Several Key Productsincluding Signateraa Ca Ctdna Assay For Detecting Molecular Residual Disease And Monitoring Recurrence In Cancerspanoramaa Ca Non Invasive Prenatal Test For Identifying Chromosomal Abnormalitiesand Prosperaa Ca Test For Monitoring Kidney Transplant Rejectionnatera Employs Advanced Molecular Biologybioinformaticsand Ai In Its Proprietary Cfdna Platformensuring High Accuracy Through Rigorous Validation And Compliance With Industry Standards Natera Serves Healthcare Providersresearchersand Patients Worldwideconducting Over 70 000 Annual Support Sessionsthe Company Is Committed To Expanding Its Test Portfolio Through Large Scale Trials And Partnershipswith A Focus On Precision Medicine And Early Disease Detection
No conferences found for this company.
| Company Name | Natera Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
